Two recent Supreme Court decisions, Trump v. United States and Loper Bright Enterprises v. Raimond, have broad implications for administrative authority and regulatory advocacy. Joseph Cantrell, JD, analyzes how these decisions may affect the relative power of the different branches of government.
Articles by From the College
Invest in RheumPAC Before a Critical Reporting Deadline
Approaching a critical Federal Election Commission reporting deadline on July 15, RheumPAC is just $976 short of its key mid-year fundraising goal.
Take Action to Modernize Prior Authorization & Streamline Access to Care
The reintroduction of the Improving Seniors’ Access to Care Act gives an opportunity to reduce administrative burden and undue delay of patient care imposed by prior authorization in Medicare Advantage plans. Contact your members of Congress today to urge them to pass this vital bill.
ACR Applauds Legislation to Reform Prior Authorization Policies
A new bill, the Improving Seniors’ Timely Access to Care Act, aims to streamline the prior authorization process. “The prior authorization process has become unmanageable for both doctors and patients. Insurer red tape imposes a significant burden on clinicians, leading to unnecessary and unclear delays, or even outright denials of patient care,” says ACR President…
State Copay Accumulator Legislation: An Overview
As uncertainty persists around federal policies regarding copay accumulator programs, a growing number of states are stepping in. A total of 21 states have banned the programs and others are increasing transparency requirements
ACR Successfully Leads Coalition in AMA House of Delegates to Support Higher Pediatric Specialist Compensation
An ACR-led resolution that calls for Medicaid payment parity for pediatric specialists will become AMA policy.
This August, Advocate with the ACR from Home
August marks an in-district work period for federal legislators. This offers a great opportunity for ACR/ARP members to engage with their lawmakers to complement the ACR’s formal lobbying efforts.
The ACR to the CMS: What You Need to Know About Biosimilars and G2211
On May 23, Drs. Chris Phillips and Rebecca Shepherd, chairs of the ACR’s Committee on Rheumatologic Care and Insurance Subcommittee, respectively, and members of the ACR’s advocacy staff team met with officials from the Centers for Medicare & Medicaid Services to discuss concerns on underwater biosimilars and restrictions on billing G2211.
Federal Regulatory Actions Against Healthcare Consolidation
In recent months, the U.S. Department of Justice and Federal Trade Commission have started to take action to rein in antitrust behavior, including banning noncompete agreements in the for-profit sector and establishing a taskforce on healthcare monopolies.
HHS Final Rule Reinstates ACA Nondiscrimination Provisions
Effective July 5, discrimination based on race, color, national origin, sex, age and disability by healthcare programs receiving federal assistance is once again prohibited. The application of Section 1557 to all HHS health programs and activities and state and federally facilitated exchanges, which had been weakened by the Trump administration, has been reinstated.
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 98
- Next Page »